Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
allergan
2
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
eli lilly
fda
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
acceleron pharma
acid sphingomyelinase deficiency
alder biopharmaceutical
alzheimer's disease
american academy of neurology
amgen
anika therapeutics
annovis bio
What
companies
2
×
approval
arguments
big
bio
black
class
commercialized
competitors
continue
debut
decades
diamond
diamond’s
drug
drugs
fda
indication
leading
life
make
mammoth
march
meeting
migraine
moves
neuro
new
ohana’s
oral
pop
potential
roundup
science
steady
street
therapeutics
therapies
wall
week
Language
unset
Current search:
allergan
×
companies
×
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
